These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The Cost-effectiveness of Genetic Screening for Familial Hypercholesterolemia: a Systematic Review. Rosso A; Pitini E; D'Andrea E; Massimi A; De Vito C; Marzuillo C; Villari P Ann Ig; 2017; 29(5):464-480. PubMed ID: 28715059 [TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of screening strategies for familial hypercholesterolaemia in Poland. Pelczarska A; Jakubczyk M; Jakubiak-Lasocka J; Banach M; Myśliwiec M; Gruchała M; Niewada M Atherosclerosis; 2018 Mar; 270():132-138. PubMed ID: 29407882 [TBL] [Abstract][Full Text] [Related]
4. Screening methods in the diagnosis and assessment of children and adolescents with familial hypercholesterolemia. Langslet G; Ose L Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):1061-6. PubMed ID: 23984929 [TBL] [Abstract][Full Text] [Related]
5. [Familial hypercholesterolemia: why screening, counselling and treatment should be integrated]. Roeters van Lennep JE; Visseren FL; Jira PE Ned Tijdschr Geneeskd; 2015; 159():A8875. PubMed ID: 26013253 [TBL] [Abstract][Full Text] [Related]
6. The effect of lomitapide on cardiovascular outcome measures in homozygous familial hypercholesterolemia: A modelling analysis. Leipold R; Raal F; Ishak J; Hovingh K; Phillips H Eur J Prev Cardiol; 2017 Nov; 24(17):1843-1850. PubMed ID: 28925748 [TBL] [Abstract][Full Text] [Related]
7. [Familial hypercholesterolemia: A largely underestimated cardiovascular risk]. Ferrières J; Bruckert É; Béliard S; Rabès JP; Farnier M; Krempf M; Cariou B; Danchin N Ann Cardiol Angeiol (Paris); 2018 Feb; 67(1):1-8. PubMed ID: 28576280 [TBL] [Abstract][Full Text] [Related]
9. Referral Patterns and Cascade Screening for Familial Hypercholesterolemia in a Pediatric Lipid Clinic. Stempel H; Dodge A; Marriott E; Peterson AL J Pediatr; 2016 Nov; 178():285-287. PubMed ID: 27592098 [TBL] [Abstract][Full Text] [Related]
10. Reverse Cascade Screening for Familial Hypercholesterolemia. Vinson A; Guerra L; Hamilton L; Wilson DP; Fnla J Pediatr Nurs; 2019; 44():50-55. PubMed ID: 30683281 [TBL] [Abstract][Full Text] [Related]
11. Integration of child-parent screening and cascade testing for familial hypercholesterolaemia. Wald DS; Wald NJ J Med Screen; 2019 Jun; 26(2):71-75. PubMed ID: 30319009 [TBL] [Abstract][Full Text] [Related]
12. Cascade screening for familial hypercholesterolemia from pediatric index cases diagnosed through universal screening. Lentz M; Benoy M; Zhang X; Peterson AL J Clin Lipidol; 2024; 18(4):e620-e624. PubMed ID: 38942689 [TBL] [Abstract][Full Text] [Related]
13. Cascade screening of familial hypercholesterolemia must go on. Galema-Boers JM; Versmissen J; Roeters van Lennep HW; Dusault-Wijkstra JE; Williams M; Roeters van Lennep JE Atherosclerosis; 2015 Oct; 242(2):415-7. PubMed ID: 26282946 [TBL] [Abstract][Full Text] [Related]
14. Clinical determinants and treatment gaps in familial hypercholesterolemia: Data from a multi-ethnic regional health service. Zafrir B; Jubran A; Lavie G; Halon DA; Flugelman MY; Shapira C Eur J Prev Cardiol; 2017 May; 24(8):867-875. PubMed ID: 28186442 [TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and treatment of familial hypercholesterolemia in Spain: Consensus document]. Mata P; Alonso R; Ruiz A; Gonzalez-Juanatey JR; Badimón L; Díaz-Díaz JL; Muñoz MT; Muñiz O; Galve E; Irigoyen L; Fuentes-Jiménez F; Dalmau J; Pérez-Jiménez F Semergen; 2015; 41(1):24-33. PubMed ID: 25042971 [TBL] [Abstract][Full Text] [Related]
16. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry. O'Brien EC; Roe MT; Fraulo ES; Peterson ED; Ballantyne CM; Genest J; Gidding SS; Hammond E; Hemphill LC; Hudgins LC; Kindt I; Moriarty PM; Ross J; Underberg JA; Watson K; Pickhardt D; Rader DJ; Wilemon K; Knowles JW Am Heart J; 2014 Mar; 167(3):342-349.e17. PubMed ID: 24576518 [TBL] [Abstract][Full Text] [Related]
18. An evaluation of the cost-effectiveness of population genetic screening for familial hypercholesterolemia in US patients. Hendy LE; Spees LP; Tak C; Carpenter DM; Thomas KC; Roberts MC Atherosclerosis; 2024 Jun; 393():117541. PubMed ID: 38677159 [TBL] [Abstract][Full Text] [Related]
19. Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia. Ademi Z; Watts GF; Pang J; Sijbrands EJ; van Bockxmeer FM; O'Leary P; Geelhoed E; Liew D J Clin Lipidol; 2014; 8(4):390-400. PubMed ID: 25110220 [TBL] [Abstract][Full Text] [Related]
20. Clinical phenotype in relation to the distance-to-index-patient in familial hypercholesterolemia. Besseling J; Huijgen R; Martin SS; Hutten BA; Kastelein JJ; Hovingh GK Atherosclerosis; 2016 Mar; 246():1-6. PubMed ID: 26745182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]